There are 3397 resources available
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2 - Basic Science and Translational research
Resources:
Webcast
2232O - Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031
Presenter: Carlos Barrios
Session: Proffered Paper session 2 - Basic Science and Translational research
Resources:
Abstract
Slides
Webcast
1086MO - Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results from the phase II C-144-01 study
Presenter: Evidio Domingo-Musibay
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
LBA96 - Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study
Presenter: Shun Lu
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
LBA99 - First survival data from the NIPU trial: A randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second-line treatment in patients with malignant mesothelioma
Presenter: Aaslaug Helland
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
549O - Adagrasib with or without cetuximab in patients with KRASG12C-mutated colorectal cancer (CRC): Analysis of tumor biomarkers and genomic alterations
Presenter: Meredith Pelster
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Managing disease progression in oncogene-driven lung cancer
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Optimal treatment sequence in metastatic breast cancer (mBC) in 2023
Resources:
Webcast
Discussion and Q&A
Presenter: Alice Indini
Session: Management of novel treatments’ toxicities
Resources:
Slides
Webcast